An Accurate and Rapid Screen for Early-stage Cancers!



Professor of Chemistry Stefan Bossmann and his collaborator Professor Deryl Troyer (Department of Anatomy and Physiology) have developed a nanoparticle-based screen for early stage lung- and breast cancers. The results are available within an hour and are based on sensing the specific profile of increased enzyme activity that is associated with a particular cancer. In testing, the screen achieved a 95% success rate and was capable of detecting breast cancer in stages 0 and 1, and lung cancer in stages 1 and 2. A second screening protocol, capable of delivering results in five minutes, is being developed.


For the complete story, see <here>